Rickettsia canadensis str. McKiel

Names Rickettsia canadensis str. McKiel
Accession numbers NC_009879
Background Rickettsia canadensis was first isolated from Haemaphysalis leporispalustris ticks removed from rabbits in Ontario, Canada. It was initially considered a member of the typhus group rickettsiae on the basis of antigenic similarities. However, according to recent molecular studies, it is thought to be a representative of a distinct group within the genus rickettsia, such as Rickettsia bellii. The role of Rickettsia canadensis as a human pathogen has not been definitively established. Serological evidence of infection has been reported in four patients presenting with an RMSF-like disease in California and Texas. A role for Rickettsia canadensis in acute cerebral vasculitis was also suspected in a patient from southwestern Ohio, based on serological studies that included immunoblot analysis. This description is based on PubMed 16223955. (EBI Integr8)
Strain NA
Complete Yes
Sequencing centre (02-OCT-2007) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
(10-SEP-2007) Neurogenomics Research Lab, University of Iowa, 200 B EMRB, Iowa City, IA 52242, USA
Sequencing quality Level 6: Finished
Sequencing depth NA
Sequencing method Sanger
Isolation site Ticks in Canada
Isolation country Canada
Number of replicons 1
Gram staining properties Negative
Shape Bacilli
Mobility No
Flagellar presence No
Number of membranes 2
Oxygen requirements Aerobic
Optimal temperature NA
Temperature range Mesophilic
Habitat HostAssociated
Biotic relationship Symbiotic
Host name Homo sapiens, Tick
Cell arrangement NA
Sporulation Nonsporulating
Metabolism NA
Energy source NA
Diseases Epidemic typhus
Pathogenicity Probable